Skip to main content

Jan Groen

Novigenix has appointed Jan Groen as the firm's CEO and member of its board of directors. Prior to Novigenix, Groen served as president and CEO of MDxHealth. Groen is co-founder of ViroClinics, founder and CEO of DxOrange, and currently serves on the board of Angle and Destina Genomics. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.